Work

APO-go® (apomorphine hydrochloride) delivery innovation: experiences of Dutch Parkinson’s patients switching from pre-filled syringes to cartridges

Year: 2026

Type: article

Source: Parkinsonism & Related Disorders

DOI: 10.1016/j.parkreldis.2026.108783

Authors: B. Amlani, S. Franke, D. van Bennekom, F. De Renzis, V. Correa-Gallego

Institutions: Britannia Pharmaceuticals Ltd (United Kingdom), Eurocept Group (Netherlands)

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7225196326

FWCI:

Cites:

Cited by:

Related to: 10